Sino Biopharmaceutical Limited

02/24/2021 | Press release | Distributed by Public on 02/23/2021 16:55

VOLUNTARY ANNOUNCEMENT - INTERIM ANALYSIS OF THE PHASE III CLINICAL TRIAL OF PENPULIMAB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE SQUAMOUS NONSMALL CELL LUNG CANCER HAS[...]

Read this content
The text version of this document is not available. You can access the original document here.